Earnings Call · Q4 FY2024·2025-02-27

Q4 24EPS +15.12%·Rev n/aQ3 24EPS +1.26%·Rev n/aQ2 24EPS +8.72%·Rev n/aQ1 24EPS -1.36%·Rev n/a⚠ consensus missing

COLLEGIUM PHARMACEUTICAL, INC COLL

Danielle Jesse — Investor Relations or Conference Call Host

Vikram Karnani — President and Chief Executive Officer

Scott Dreyer — Chief Commercial Officer

Colleen Tupper — Chief Financial Officer

+2.2%1d on move date+0.7% vs SPY3d−1.3%5d+4.9%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more COLL calls or request research access.

More COLL calls Browse calls Request research access